Private Equity

Managers

Creolus targets 60 mln euros for bioplastics fund

UK-based Creolus, which is focused on building the plastics industry of tomorrow, is seeking to raise 60 million euros for its first bioplastics fund. 5Capital Fund Placements is advising Creolus on the fundraising.

2 min read · 24 May 2018

Brii Biosciences racks up $260 mln

Brii Biosciences, which is focused on improving public health in China, has raised $260 million in funding. The investors include ARCH Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital and Blue Pool Capital.

1 min read · 24 May 2018

Investor confidence rises in Q1, despite valuations and cost of doing business in Silicon Valley

2 min read · 23 May 2018

Bain Capital Ventures supporting financial infrastructure for crypto assets with recent deals

2 min read · 23 May 2018

Austin, Canaan, Summit lead 2012 portfolio at Nevada pension

1 min read · 23 May 2018

CareZone pockets $50 mln Series D

CareZone, a smartphone service for managing chronic health conditions, has raised $50 million in Series D funding. NEA led the round.

3 min read · 23 May 2018

Magnetic Ventures targets $100 mln for maiden fund

Magnetic Ventures is seeking to raise $100 million for its inaugural fund, according to an SEC filing. The newly launched Magnetic Ventures will invest in early-stage medical tech companies.

1 min read · 23 May 2018

RenovoRx racks up $10 mln

Silicon Valley-based RenovoRx Inc, a medical technology company focused on treating pancreatic cancer, has raised $10 million in financing round of which the company closed $7 million in an initial tranche. Boston Scientific led the round.

1 min read · 23 May 2018

Leerink Revelation Partners and Industry Ventures-led investors acquires Three Arch's shares in AcelRx

Investors led by Leerink Revelation Partners and Industry Ventures have acquired all of the shares that were held by Three Arch in AcelRx Pharmaceuticals Inc, a specialty pharmaceutical company. No financial terms were disclosed for this secondary deal.

3 min read · 23 May 2018

Gilde Healthcare and Versant Ventures leads funding round for Lava Therapeutics

Lava Therapeutics, a Dutch biotech company, has raised 16 million euros in funding. Gilde Healthcare and Versant Ventures led the round with participation from MRL Ventures Fund, Lupus Ventures and Biox Biosciences.

1 min read · 23 May 2018

Showing 3,871 to 3,880 of 19,970 results
1…387389…1000